Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
fda approvals 2022 | 1.57 | 0.2 | 3664 | 56 | 18 |
fda | 0.13 | 0.5 | 8970 | 96 | 3 |
approvals | 0.43 | 0.8 | 8664 | 52 | 9 |
2022 | 0.2 | 0.1 | 3618 | 31 | 4 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda approvals 2022 | 0.41 | 0.4 | 7626 | 3 |
fda approvals 2020 | 1.6 | 0.4 | 1604 | 96 |
fda approvals 2023 | 1.7 | 0.3 | 6166 | 88 |
fda approvals 2021 | 1.83 | 0.8 | 7110 | 95 |
fda approvals 2024 | 1.25 | 0.2 | 4769 | 98 |
fda drug approvals 2022 | 0.44 | 0.4 | 3461 | 17 |
fda new drug approvals 2022 | 1.53 | 0.6 | 312 | 18 |
pacritinib fda approval 2022 | 0.57 | 0.2 | 2223 | 45 |
teplizumab fda approval 2022 | 1.3 | 0.5 | 3226 | 59 |
fda new drug therapy approvals 2022 | 0.43 | 0.2 | 6280 | 45 |
tirzepatide fda approval 2022 | 1.9 | 0.7 | 3834 | 14 |
evo visian icl fda approval 2022 | 0.42 | 0.2 | 9329 | 60 |